Showing results (1-10 of 20) with videos related to
Sort By:
Pageof 2
Journal of Chromatography|July 1, 1978
Microdetermination of caffeine in blood by gas chromatography--mass spectrometryR L Merriman, A Swanson, M W Anders, et al.Drug Metabolism and Disposition: the Biological Fate of Chemicals|July 1, 1978
Differential effects of Walker 256 carcinosarcoma cells growing subcutaneously, intramuscularly, or intraperitoneally on hepatic microsomal mixed-function oxygenase activityN E Sladek, B E Domeyer, R L Merriman, et al.Cancer Research|August 15, 1989
Drug treatments for metastasis of the Lewis lung carcinoma: lack of correlation between inhibition of lung metastasis and survivalR L Merriman, K A Shackelford, L R Tanzer, et al.American Journal of Surgery|February 1, 1995
Development and characterization of normal colonic epithelial cell lines derived from normal mucosa of patients with colon cancerJ S Stauffer, L A Manzano, G C Balch, et al.Cancer Research|September 2, 2000
Metabolism and pharmacokinetics of N1,N11-diethylnorspermine in a Cebus apella primate modelR J Bergeron, R L Merriman, S G Olson, et al.Cancer Letters|September 10, 1996
H-ras transfection of the rat kidney cell line NRK-52E results in increased induction of c-fos, c-jun and hsp70 following sulofenur treatmentH Gu, M W Smith, P C Phelps, et al.Cancer Letters|October 20, 1995
Studies on the mechanism of sulofenur and LY295501 toxicity: effect on the regulation of cytosolic calcium in relation to cytotoxicity in normal and tumorigenic rat kidney cell linesP C Phelps, C J Best, I K Berezesky, et al.In Vitro Cellular & Developmental Biology. Animal|September 9, 1999
H-ras-transformed NRK-52E renal epithelial cells have altered growth, morphology, and cytoskeletal structure that correlates with renal cell carcinoma in vivoC J Best, L R Tanzer, P C Phelps, et al.Journal of Medicinal Chemistry|January 29, 2000
Synthesis and evaluation of hydroxylated polyamine analogues as antiproliferativesR J Bergeron, R Müller, J Bussenius, et al.The Journal of Urology|February 1, 1992
Inhibition of PAIII rat prostatic adenocarcinoma growth and metastasis by a new diarylsulfonylurea antitumor agent, LY181984B L Neubauer, R L Merriman, K L Best, et al.Pageof 2